Allergan Ltd - Company Profile
Powered by
All the data and insights you need on Allergan Ltd in one report.
- Save hours of research time and resources with
our up-to-date Allergan Ltd Strategy Report
- Understand Allergan Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Allergan Ltd (Allergan), a subsidiary of AbbVie Inc, is a specialty pharmaceutical company that develops and markets branded pharmaceuticals and biosimilar, and over-the-counter (OTC) pharmaceutical products. The company offers products in the areas of eye care, medical esthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. It sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations across the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Allergan is headquartered in Dublin, Ireland.
Allergan Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Actigall capsules | Aczone |
ACTONEL (risedronate sodium) | Alphagan/Combigan |
ACULAR (ketorolac tromethamine ophthalmic solution) | Asacol/Delzicol |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Allergan Ltd | Pfizer Inc | AstraZeneca Plc | Bristol-Myers Squibb Co | GSK plc |
---|---|---|---|---|---|
Headquarters | Ireland | United States of America | United Kingdom | United States of America | United Kingdom |
City | Dublin | New York | Cambridge | Princeton | Brentford |
State/Province | Leinster | New York | England | New Jersey | England |
No. of Employees | - | 88,000 | 89,900 | 34,100 | 70,212 |
Entity Type | Private | Public | Public | Public | Public |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Brenton L. Saunders | President; Chief Executive Officer; Chairman | Executive Board | 2016 | 52 |
Matthew M. Walsh | Executive Vice President; Chief Financial Officer | Senior Management | 2018 | 55 |
A. Robert D. Bailey | Secretary; Chief Legal Officer; Executive Vice President | Senior Management | 2014 | 58 |
Alex Kelly | Chief Communications Officer; Executive Vice President | Senior Management | 2015 | - |
C. David Nicholson, Ph.D. | Chief Research and Development Officer; Executive Vice President | Senior Management | 2015 | 66 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer